Cat. No.: HY-117867

AVE-8063

Name: AVE-8063
Brand: MedChemExpress
SKU: HY-117867
Price: 25.00 USD
Availability: InStock
Rating: 5 (1 reviews)

(Synonyms: AC-7739 free base)

Customer Review

Based on 1 Customer Validation

AVE-8063 (AC-7739 free base) is an aminocombretastatin. AVE-8063 shows potent antitubulin activity and cytotoxicity. AVE-8063 can be used in the research of leukemia and breast cancer.

For research use only. We do not sell to patients.

Purity : 97.04%
CAS No.: 162705-07-9
Formula: C₁₈H₂₁NO₄
Molecular Weight:315.37

Storage:

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

AVE-8063 Chemical Structure

CAS No.: 162705-07-9

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- Cellular Effect
Chemical Information
Solvent & Solubility
- In Vitro
- In Vivo
Purity & Documentation
References
Help & FAQs
Classifications
Bioz

Biological Activity

Description

AVE-8063 (AC-7739 free base) is an aminocombretastatin. AVE-8063 shows potent antitubulin activity and cytotoxicity. AVE-8063 can be used in the research of leukemia and breast cancer^[1]^[2].

Cellular Effect

Cell Line	Type	Value	Description	References
3LL cell line	IC₅₀	12 nM Compound: 67	Antitumor activity against mouse 3LL cells transplanted in to BALB/c mouse assessed as tumor growth inhibition at 10 mg/kg, ip qd for 4 days Antitumor activity against mouse 3LL cells transplanted in to BALB/c mouse assessed as tumor growth inhibition at 10 mg/kg, ip qd for 4 days	[PMID: 20690624]
A549	IC₅₀	117 nM Compound: AmCA-4	Antiproliferative activity against human A549 cells after 2 days by MTT assay Antiproliferative activity against human A549 cells after 2 days by MTT assay	[PMID: 29432949]
A549	IC₅₀	117 nM Compound: AmCA-4	Antiproliferative activity against human A549 cells by MTT assay Antiproliferative activity against human A549 cells by MTT assay	[PMID: 30502686]
A549	IC₅₀	51.2 nM Compound: 15	Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	[PMID: 31401010]
BJ	IC₅₀	87.3 nM Compound: 15	Cytotoxicity against human BJ cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay Cytotoxicity against human BJ cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	[PMID: 31401010]
BXPC-3	GI₅₀	0.43 ng/mL Compound: 8f	Growth inhibition against human pancreas carcinoma cell line (BxPC-3) Growth inhibition against human pancreas carcinoma cell line (BxPC-3)	[PMID: 15943482]
CCRF-CEM	IC₅₀	51.2 nM Compound: 15	Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	[PMID: 31401010]
CEM-DNR	IC₅₀	15.7 nM Compound: 15	Cytotoxicity against human CEM/DNR cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay Cytotoxicity against human CEM/DNR cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	[PMID: 31401010]
Colon 26	IC₅₀	2.8 nM Compound: 5	Antiproliferative activity against mouse Colon 26 cells assessed as inhibition of cell growth Antiproliferative activity against mouse Colon 26 cells assessed as inhibition of cell growth	[PMID: 23454513]
Colon 26	IC₅₀	5.1 nM Compound: 21a	Growth inhibition of colon 26 adenocarcinoma cells by 50 %. Growth inhibition of colon 26 adenocarcinoma cells by 50 %.	[PMID: 9685242]
DU-145	GI₅₀	0.33 ng/mL Compound: 8f	Growth inhibition against human prostate cell line (DU-145) Growth inhibition against human prostate cell line (DU-145)	[PMID: 15943482]
DU-145	GI₅₀	0.96 ng/mL Compound: 3'-NH2-CA4	Cytotoxicity against human DU145 cells after 48 hrs by SRB assay Cytotoxicity against human DU145 cells after 48 hrs by SRB assay	[PMID: 18710804]
DU-145	GI₅₀	3.3 nM Compound: 3' CA4-amine	Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay Cytotoxicity against human DU145 cells assessed as growth inhibition after 48 hrs by SRB assay	[PMID: 26852340]
FaDu	GI₅₀	0.53 ng/mL Compound: 8f	Growth inhibition against human pharynx FADU cell line Growth inhibition against human pharynx FADU cell line	[PMID: 15943482]
HCT-116	IC₅₀	269 nM Compound: 67	Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay	[PMID: 20690624]
HCT-116	IC₅₀	3.17 nM Compound: 15	Cytotoxicity against p53 deficient human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay Cytotoxicity against p53 deficient human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	[PMID: 31401010]
HCT-116	IC₅₀	3.18 nM Compound: 15	Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	[PMID: 31401010]
HCT-15	IC₅₀	45.2 nM Compound: 67	Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay	[PMID: 20690624]
HCT-15	IC₅₀	6.5 μM Compound: 67	Inhibition of tubulin polymerization in multidrug-resistant human HCT15 cells after 1 hr Inhibition of tubulin polymerization in multidrug-resistant human HCT15 cells after 1 hr	[PMID: 20690624]
HEK293	IC₅₀	7.1 nM Compound: AmCA-4	Antiproliferative activity against HEK293 cells after 2 days by MTT assay Antiproliferative activity against HEK293 cells after 2 days by MTT assay	[PMID: 29432949]
HEK293	IC₅₀	7.1 nM Compound: AmCA-4	Antiproliferative activity against HEK293 cells by MTT assay Antiproliferative activity against HEK293 cells by MTT assay	[PMID: 30502686]
HeLa	CC₅₀	1.47 nM Compound: 3	Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by cell titer blue assay Cytotoxicity against human HeLa cells assessed as reduction in cell viability measured after 72 hrs by cell titer blue assay	[PMID: 31413794]
HeLa	IC₅₀	0.403 μM Compound: 3, AVE8063	Cytotoxicity against human HeLa cells after 24 hrs by MTT assay Cytotoxicity against human HeLa cells after 24 hrs by MTT assay	[PMID: 23369687]
HeLa	IC₅₀	0.53 nM Compound: 19	Cytotoxicity against human HeLa cells by MTT assay Cytotoxicity against human HeLa cells by MTT assay	[PMID: 19879758]
HeLa	IC₅₀	2.6 nM Compound: AmCA-4	Antiproliferative activity against human HeLa cells after 2 days by MTT assay Antiproliferative activity against human HeLa cells after 2 days by MTT assay	[PMID: 29432949]
HeLa	IC₅₀	2.6 nM Compound: AmCA-4	Antiproliferative activity against human HeLa cells by MTT assay Antiproliferative activity against human HeLa cells by MTT assay	[PMID: 30502686]
HepG2	IC₅₀	0.028 μM Compound: 3, AVE8063	Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay	[PMID: 23369687]
HL-60	IC₅₀	0.012 μM Compound: AVE-8063	Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay	[PMID: 20850313]
HL-60	IC₅₀	12 nM Compound: 67	Cytotoxicity against human HL60 cells after 72 hrs by MTT assay Cytotoxicity against human HL60 cells after 72 hrs by MTT assay	[PMID: 20690624]
HL-60	IC₅₀	4.5 nM Compound: AmCA-4	Antiproliferative activity against human HL60 cells after 2 days by MTT assay Antiproliferative activity against human HL60 cells after 2 days by MTT assay	[PMID: 29432949]
HL-60	IC₅₀	4.5 nM Compound: AmCA-4	Antiproliferative activity against human HL60 cells by MTT assay Antiproliferative activity against human HL60 cells by MTT assay	[PMID: 30502686]
HMEC-1	IC₅₀	0.012 μM Compound: AmCA-4	Antiangiogenic activity against HMEC1 cells after 20 hrs by tube formation assay Antiangiogenic activity against HMEC1 cells after 20 hrs by tube formation assay	[PMID: 30502686]
HMEC-1	IC₅₀	12 nM Compound: AmCA-4	Antiproliferative activity against HMEC1 cells after 2 days by MTT assay Antiproliferative activity against HMEC1 cells after 2 days by MTT assay	[PMID: 29432949]
HMEC-1	IC₅₀	12 nM Compound: AmCA-4	Antiproliferative activity against HMEC1 cells by MTT assay Antiproliferative activity against HMEC1 cells by MTT assay	[PMID: 30502686]
HT-29	IC₅₀	22 nM Compound: AmCA-4	Antiproliferative activity against human HT-29 cells after 2 days by MTT assay Antiproliferative activity against human HT-29 cells after 2 days by MTT assay	[PMID: 29432949]
HT-29	IC₅₀	22 nM Compound: AmCA-4	Antiproliferative activity against human HT-29 cells by MTT assay Antiproliferative activity against human HT-29 cells by MTT assay	[PMID: 30502686]
HT-29	IC₅₀	5 nM Compound: 3b, ST-3100	Cytotoxic activity against human HT29 cells after 72 hrs by sulforhodamine B test Cytotoxic activity against human HT29 cells after 72 hrs by sulforhodamine B test	[PMID: 18396857]
HT-29	IC₅₀	5 nM Compound: 9, AVE-8063	Antiproliferative activity against human HT29 cell line by methylene blue dye assay Antiproliferative activity against human HT29 cell line by methylene blue dye assay	[PMID: 17034147]
HT-29	IC₅₀	7.9 nM Compound: AVE-8063	In vitro cytotoxic activity against human HT-29 cell line of colorectal carcinoma In vitro cytotoxic activity against human HT-29 cell line of colorectal carcinoma	[PMID: 15139768]
Huh-7	CC₅₀	>100 μM Compound: 3	Cytotoxicity against human HuH7 cells assessed as reduction in cell viability measured after 24 hrs by cell titer blue assay Cytotoxicity against human HuH7 cells assessed as reduction in cell viability measured after 24 hrs by cell titer blue assay	[PMID: 31413794]
Huh-7	CC₅₀	3.93 nM Compound: 3	Cytotoxicity against human HuH7 cells assessed as reduction in cell viability measured after 72 hrs by cell titer blue assay Cytotoxicity against human HuH7 cells assessed as reduction in cell viability measured after 72 hrs by cell titer blue assay	[PMID: 31413794]
HUVEC	IC₅₀	11.3 nM Compound: 15	Cytotoxicity against HUVEC assessed as reduction in cell viability incubated for 72 hrs by MTS assay Cytotoxicity against HUVEC assessed as reduction in cell viability incubated for 72 hrs by MTS assay	[PMID: 31401010]
K562	IC₅₀	0.12 μM Compound: 3, AVE8063	Cytotoxicity against human K562 cells after 24 hrs by MTT assay Cytotoxicity against human K562 cells after 24 hrs by MTT assay	[PMID: 23369687]
K562	IC₅₀	15.7 nM Compound: 15	Cytotoxicity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay Cytotoxicity against human K562 cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	[PMID: 31401010]
KB	IC₅₀	7 nM Compound: 9, AVE-8063	Antiproliferative activity against human KB cell line by methylene blue dye assay Antiproliferative activity against human KB cell line by methylene blue dye assay	[PMID: 17034147]
KB	IC₅₀	8.2 nM Compound: AVE-8063	In vitro cytotoxic activity against human KB cell line of epidermoid carcinoma In vitro cytotoxic activity against human KB cell line of epidermoid carcinoma	[PMID: 15139768]
MCF7	IC₅₀	0.0035 μM Compound: 19	Cytotoxicity against human MCF7 cells by MTT assay Cytotoxicity against human MCF7 cells by MTT assay	[PMID: 19879758]
MCF7	IC₅₀	8 nM Compound: AmCA-4	Antiproliferative activity against human MCF7 cells after 2 days by MTT assay Antiproliferative activity against human MCF7 cells after 2 days by MTT assay	[PMID: 29432949]
MCF7	IC₅₀	8 nM Compound: AmCA-4	Antiproliferative activity against human MCF7 cells by MTT assay Antiproliferative activity against human MCF7 cells by MTT assay	[PMID: 30502686]
MDA-MB-231	IC₅₀	12 nM Compound: AmCA-4	Antiproliferative activity against human MDA-MB-231 cells after 3 days by coulter counting method Antiproliferative activity against human MDA-MB-231 cells after 3 days by coulter counting method	[PMID: 29432949]
MDA-MB-231	IC₅₀	45 nM Compound: AVE-8063	Antiproliferative activity against P-gp expressing multidrug-resistant human MDA-MB-231 cells after 72 hrs by MTT assay Antiproliferative activity against P-gp expressing multidrug-resistant human MDA-MB-231 cells after 72 hrs by MTT assay	[PMID: 20850313]
MKN-45	IC₅₀	5.1 nM Compound: 9, AVE-8063	Antiproliferative activity against human MKN45 cell line by methylene blue dye assay Antiproliferative activity against human MKN45 cell line by methylene blue dye assay	[PMID: 17034147]
NCI-H460	GI₅₀	0.33 ng/mL Compound: 8f	Growth inhibition against human lung-NSC NCI-H460 cell line Growth inhibition against human lung-NSC NCI-H460 cell line	[PMID: 15943482]
NCI-H460	GI₅₀	0.68 ng/mL Compound: 3'-NH2-CA4	Cytotoxicity against human NCI-H460 cells after 48 hrs by SRB assay Cytotoxicity against human NCI-H460 cells after 48 hrs by SRB assay	[PMID: 18710804]
NCI-H460	GI₅₀	4.49 nM Compound: 3' CA4-amine	Cytotoxicity against human NCI-H460 cells assessed as growth inhibition after 48 hrs by SRB assay Cytotoxicity against human NCI-H460 cells assessed as growth inhibition after 48 hrs by SRB assay	[PMID: 26852340]
NCI-H460	IC₅₀	4.9 nM Compound: 3b, ST-3100	Cytotoxic activity against human NCI-H460 cells after 72 hrs by sulforhodamine B test Cytotoxic activity against human NCI-H460 cells after 72 hrs by sulforhodamine B test	[PMID: 18396857]
NCI-H460	IC₅₀	9 nM Compound: 9, AVE-8063	Antiproliferative activity against human H460 cell line by methylene blue dye assay Antiproliferative activity against human H460 cell line by methylene blue dye assay	[PMID: 17034147]
P388	ED₅₀	>0.01 μg/mL Compound: 8f	Effective dose against murine P388 leukemia cell line Effective dose against murine P388 leukemia cell line	[PMID: 15943482]
SK-N-SH	GI₅₀	0.23 ng/mL Compound: 8f	Growth inhibition against human neuroblastoma cell line (SK-N-SH) Growth inhibition against human neuroblastoma cell line (SK-N-SH)	[PMID: 15943482]
SK-OV-3	GI₅₀	4.45 nM Compound: 3' CA4-amine	Cytotoxicity against human SKOV3 cells assessed as growth inhibition after 48 hrs by SRB assay Cytotoxicity against human SKOV3 cells assessed as growth inhibition after 48 hrs by SRB assay	[PMID: 26852340]
SW-1736	GI₅₀	0.8 ng/mL Compound: 8f	Growth inhibition against human thyroid cell line( SW 1736) Growth inhibition against human thyroid cell line( SW 1736)	[PMID: 15943482]
TSGH	IC₅₀	7.7 nM Compound: AVE-8063	In vitro cytotoxic activity against human TSGH cell line of stomach carcinoma In vitro cytotoxic activity against human TSGH cell line of stomach carcinoma	[PMID: 15139768]
TSGH 9201	IC₅₀	7 nM Compound: 9, AVE-8063	Antiproliferative activity against human TSGH stomach carcinoma cell line by methylene blue dye assay Antiproliferative activity against human TSGH stomach carcinoma cell line by methylene blue dye assay	[PMID: 17034147]
U2OS	IC₅₀	6 nM Compound: 15	Cytotoxicity against human U2OS cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay Cytotoxicity against human U2OS cells assessed as reduction in cell viability incubated for 72 hrs by MTS assay	[PMID: 31401010]

Chemical Information

CAS No. 162705-07-9
Appearance Liquid
Molecular Weight 315.37
Formula C₁₈H₂₁NO₄
Color Yellow to brown
SMILES

O(C)C1=C(OC)C=C(/C=C\C2=CC(N)=C(OC)C=C2)C=C1OC
Synonyms

AC-7739 free base
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (317.09 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

3.1709 mL

15.8544 mL

31.7088 mL

5 mM

0.6342 mL

3.1709 mL

6.3418 mL

10 mM

0.3171 mL

1.5854 mL

3.1709 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (7.93 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: 2.5 mg/mL (7.93 mM); Suspended solution; Need ultrasonic

This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (275 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Kamal A, et al. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers. Bioorg Med Chem. 2014 Oct 1;22(19):5155-67. [Content Brief]

[2]. Lee J, et al. Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analog. Bioorg Med Chem Lett. 2010 Nov 1;20(21):6327-30. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	3.1709 mL	15.8544 mL	31.7088 mL	79.2720 mL
	5 mM	0.6342 mL	3.1709 mL	6.3418 mL	15.8544 mL
	10 mM	0.3171 mL	1.5854 mL	3.1709 mL	7.9272 mL
	15 mM	0.2114 mL	1.0570 mL	2.1139 mL	5.2848 mL
	20 mM	0.1585 mL	0.7927 mL	1.5854 mL	3.9636 mL
	25 mM	0.1268 mL	0.6342 mL	1.2684 mL	3.1709 mL
	30 mM	0.1057 mL	0.5285 mL	1.0570 mL	2.6424 mL
	40 mM	0.0793 mL	0.3964 mL	0.7927 mL	1.9818 mL
	50 mM	0.0634 mL	0.3171 mL	0.6342 mL	1.5854 mL
	60 mM	0.0528 mL	0.2642 mL	0.5285 mL	1.3212 mL
	80 mM	0.0396 mL	0.1982 mL	0.3964 mL	0.9909 mL
	100 mM	0.0317 mL	0.1585 mL	0.3171 mL	0.7927 mL

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

AVE-8063